Epilepsy is a chronic disorder resulting
in repeated and unprovoked seizures. Epileptic seizures are commonly referred
as convulsions. Anticonvulsants are mainly used for the treatment of epileptic
seizures. In addition, anticonvulsants are also used in treatment of bipolar
disorder and in neuropathic pain management.
Browse Full Report With TOC: http://www.mrrse.com/analysis/211669
Epilepsy can affect people of any
age group. Though brain injury, brain cancer, drug and alcohol misuse and
stroke are some of the reasons for epileptic seizures, exact reason for
convulsions is not known. Some of the common symptoms occur before convulsions
include, visual loss, strange feeling, nausea, numbness in body parts, headache
and racing thoughts. Increasing awareness about anticonvulsants available in
the market, patent expiration of many patented drugs are some of the major
factors that are driving epileptic anticonvulsants market towards growth.
While, cost advantage and convenient dosage forms of currently available
generic anticonvulsants are restraining the growth of novel therapies in the
epileptic anticonvulsants market. On the basis of therapeutic indication for
which anticonvulsants are used, epileptic anticonvulsants market is segmented
as follows:
- Epilepsy
- Fibromyalgia
- Migraine
- Neuropathic pain
- Bipolar disorder
- Anxiety
Based on type of drugs, epileptic
anticonvulsants market is segmented as follows:
- Barbiturates
- Aldehydes
- Benzodiazepines
- Aromatic allylic alcohols
- Carboxamides
- Bromides
- Carbamates
- Sulfonamides
- Fructose derivatives
- Pyrrolidines
- Triazines
- Fatty acids
- Oxazolidinediones
- Ureas
- GABA analogs
- Propionates
- Hydantoins
- Pyrimidinediones
- Succinimides
- Valproylamides (amide derivatives of valproate)
- Others
Currently, North America dominates
the global epileptic anticonvulsants market and is followed by Europe. Factors
such as highly developed healthcare infrastructure, high healthcare spending,
high rate of awareness about epilepsy and related treatments and availability
of skilled healthcare professionals to treat epilepsy are driving North
American epileptic anticonvulsants market towards growth. Asia-Pacific is a
lucrative region for epileptic anticonvulsants.
Some of the factors such as
increasing healthcare spending, rapidly improving healthcare infrastructure and
increasing government initiatives to offer improved healthcare facilities on
the ground of rapidly growing medical tourism industry in this region are
likely to fuel the growth of epileptic anticonvulsants market. Asia Pacific
countries mainly India and China are expected to show swift growth in the
epileptic anticonvulsants market owing to the growth of medical tourism
industry in these countries at a faster rate than other counties in the
Asia-Pacific region. Apart from India and China, Japan will play a significant
role in the Asia Pacific epileptic anticonvulsants market owing to heavy
investment and increasing involvement of Japanese government to improve
healthcare infrastructure in the country. Latin American countries mainly,
Brazil, Mexico and Argentina have growth potential in the epileptic
anticonvulsants market.
Factors such as well defined
regulatory framework, availability of pharmaceutical manufacturing facilities
and supportive economy are likely to result in the growth of epileptic
anticonvulsants market in Latin America. While on the other hand, African
countries are expected to show low growth rate in epileptic anticonvulsants
market owing to poor economy, lack of healthcare facilities and healthcare
professionals. Some of the major companies contributing to the global anticonvulsants
market are Johnson & Johnson (J&J), Novartis AG, UCB Group,
GlaxoSmithKline plc, Pfizer Inc. and Abbott Laboratories.
To Get Download Full Report with TOC: http://www.mrrse.com/sample/toc/211669
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review of
micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Contact Us
State Tower
90 State Street, Suite
700
Albany, NY 12207
United States
Toll Free: 866-997-4948
(USA-CANADA)
Tel: +1-518-618-1030
